Comparative thrombotic risk associated with CALR1, CALR2, and JAK2 V617F mutations in essential thrombocythemia

被引:1
|
作者
Neupane, Niraj [1 ]
Low, Soon K. [2 ]
Kharel, Himal [1 ]
Bhattarai, Sanket [3 ]
Thapa, Sangharsha [4 ]
Mahmoud, Amir [1 ]
Pokhrel, Nishant B. [5 ]
Din, Mohammad Ammad Ud [6 ]
Kouides, Peter [7 ]
机构
[1] Rochester Gen Hosp, Dept Internal Med, Rochester, NY 14621 USA
[2] Med Coll Wisconsin, Dept Hematol & Oncol, Milwaukee, WI USA
[3] Mayo Clin, Rochester, MN USA
[4] New York Med Coll, Westchester Med Ctr, Dept med, Westchester, NY USA
[5] Norwalk Hosp, Dept Internal Med, Norwalk, CT USA
[6] H Lee Moffitt Canc Ctr & Res Inst, Dept Hematol & Oncol, Tampa, FL USA
[7] Rochester Gen Hosp, Lipson Canc Inst, Dept Hematol, Rochester, NY USA
关键词
PROGNOSIS; SUBTYPES;
D O I
10.1002/ajh.27148
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E26 / E28
页数:3
相关论文
共 50 条
  • [31] Clinical implications of the JAK2 V617F mutation in essential thrombocythemia
    E Antonioli
    P Guglielmelli
    A Pancrazzi
    C Bogani
    M Verrucci
    V Ponziani
    G Longo
    A Bosi
    A M Vannucchi
    Leukemia, 2005, 19 : 1847 - 1849
  • [32] INFLUENCE OF THE CARDIOVASCULAR RISK FACTORS AND V617F JAK2 MUTATION IN THE THROMBOTIC RISK IN YOUNG PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA
    Gomez Virginia, Escamilla
    Cuadrado Isabel, Montero
    Maria Angeles, Munoz
    Campos Jose, Gonzalez
    Francisco Jose, Marquez Malaver
    Jose Antonio, Perez Simon
    HAEMATOLOGICA, 2016, 101 : 155 - 155
  • [33] Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia
    Munazza Rashid
    Rifat Zubair Ahmed
    Shariq Ahmed
    Muhammad Nadeem
    Nuzhat Ahmed
    Tahir Sultan Shamsi
    Indian Journal of Hematology and Blood Transfusion, 2016, 32 : 112 - 116
  • [34] CALR but Not JAK2 Mutations Are Associated with an Overexpression of Retinoid X Receptor Alpha in Essential Thrombocythemia
    Guijarro-Hernandez, Ana
    Hurtado, Cristina
    Larrayoz, Maria Jose
    Calasanz, Maria Jose
    Vizmanos, Jose Luis
    CANCERS, 2024, 16 (08)
  • [35] Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia
    Rashid, Munazza
    Ahmed, Rifat Zubair
    Ahmed, Shariq
    Nadeem, Muhammad
    Ahmed, Nuzhat
    Shamsi, Tahir Sultan
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2016, 32 : S112 - S116
  • [36] Hematological relevance of JAK2 V617F and calreticulin mutations in Tunisian patients with essential thrombocythemia
    Abdelghani, Maroua
    Hammami, Haifa
    Zidi, Wiem
    Amouri, Hassiba
    Othmen, Hind Ben Hadj
    Farrah, Ahlem
    Menif, Samia
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (08)
  • [37] Significance of combined detection of JAK2V617F, MPL and CALR gene mutations in patients with essential thrombocythemia
    Ji, Liying
    Qian, Mengyao
    Wu, Nana
    Wu, Jianmin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 13 (03) : 947 - 951
  • [38] JAK2 V617F, hemostatic polymorphisms, and clinical features as risk factors for arterial thrombotic events in essential thrombocythemia
    Moreno, Maria J.
    Lozano, Maria L.
    Roldan, V.
    Bellosillo, B.
    Garcia-Barbera, N.
    Rivera, J.
    Navarro-Nunez, L.
    Besses, C.
    Vicente, V.
    Martinez, C.
    ANNALS OF HEMATOLOGY, 2008, 87 (09) : 763 - 765
  • [39] JAK2 V617F, hemostatic polymorphisms, and clinical features as risk factors for arterial thrombotic events in essential thrombocythemia
    María J. Moreno
    María L. Lozano
    V. Roldán
    B. Bellosillo
    N. García-Barberá
    J. Rivera
    L. Navarro-Núñez
    C. Besses
    V. Vicente
    C. Martínez
    Annals of Hematology, 2008, 87 : 763 - 765
  • [40] Selected Parameters of Angiogenesis and the JAK2, CALR, and MPL Mutations in Patients With Essential Thrombocythemia
    Gadomska, Grazyna
    Bartoszewska-Kubiak, Alicja
    Boinska, Joanna
    Matiakowska, Karolina
    Ziolkowska, Katarzyna
    Haus, Olga
    Rosc, Danuta
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (07) : 1056 - 1060